Found 14 matching trials
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy N/A This study is for people who have geographic atrophy due to age-related mac...
Show More Location
Phoenix Retina Clinical Trials, LLC
Learn More & Join Trial
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD PHASE2 The purpose of this study is to collect efficacy and safety information of ...
Show More Location
Associated Retina Consultants
Learn More & Join Trial
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration PHASE4 Age-related macular degeneration (AMD) is an eye disease which causes peopl...
Show More Status
Active Not Recruiting
Location
Nagoya City University Hospital
Learn More & Join Trial
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) PHASE1 The main purpose of this study is to assess the ocular and systemic safety ...
Show More Location
Associated Retina Consultants - Phoenix - DocTrials - PPDS
Learn More & Join Trial
ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD) PHASE2 To assess the safety of intravitreal Zimura™ (complement factor C5 inhibito...
Show More Location
Retinal Research Institute
Learn More & Join Trial
Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration PHASE2 The objectives of this study were to evaluate the safety and efficacy of Zi...
Show More Location
Multiple Locations
Learn More & Join Trial
ARC1905 (Anti-C5 Aptamer) Given With Lucentis 0.5 mg In People With Neovascular Age-Related Macular Degeneration PHASE1 The objectives of this study are to evaluate the safety, tolerability, and ...
Show More Learn More & Join Trial
A Study to Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) PHASE2 The objectives of this study are to evaluate the safety and tolerability of...
Show More Location
Multiple Locations
Learn More & Join Trial
ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) PHASE2 To asses the safety of intravitreal Zimura™ (complement factor C5 inhibitor...
Show More Location
Retina Consultants of Hawaii
Learn More & Join Trial
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) PHASE3 The objectives of this study was to evaluate the safety and efficacy of ava...
Show More Location
Retina-Vitreous Associates Medical Group
Learn More & Join Trial